Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neisseria gonorrhoeae | 48 | 2024 | 238 | 15.860 |
Why?
|
Gonorrhea | 40 | 2024 | 341 | 14.610 |
Why?
|
Drug Resistance, Bacterial | 30 | 2024 | 1031 | 5.790 |
Why?
|
Anti-Bacterial Agents | 59 | 2024 | 7269 | 5.410 |
Why?
|
Genome, Bacterial | 15 | 2021 | 766 | 3.180 |
Why?
|
Drug Resistance, Microbial | 10 | 2023 | 858 | 3.000 |
Why?
|
Microbial Sensitivity Tests | 31 | 2024 | 1885 | 2.810 |
Why?
|
Ciprofloxacin | 9 | 2024 | 314 | 2.680 |
Why?
|
Azithromycin | 11 | 2023 | 196 | 2.250 |
Why?
|
Respiratory Tract Infections | 4 | 2023 | 980 | 1.530 |
Why?
|
Macrolides | 5 | 2022 | 203 | 1.520 |
Why?
|
Disease Outbreaks | 10 | 2024 | 1785 | 1.500 |
Why?
|
Cephalosporin Resistance | 3 | 2020 | 17 | 1.340 |
Why?
|
Molecular Epidemiology | 9 | 2020 | 468 | 1.270 |
Why?
|
Escherichia coli Infections | 4 | 2023 | 533 | 1.130 |
Why?
|
Neisseria meningitidis | 4 | 2022 | 109 | 1.090 |
Why?
|
Homosexuality, Male | 9 | 2024 | 1247 | 1.080 |
Why?
|
Basketball | 5 | 2024 | 49 | 1.050 |
Why?
|
Doxycycline | 2 | 2023 | 329 | 1.020 |
Why?
|
Bacterial Proteins | 11 | 2022 | 3860 | 1.020 |
Why?
|
Staphylococcal Infections | 7 | 2023 | 1405 | 0.950 |
Why?
|
Drug Utilization | 3 | 2019 | 1180 | 0.940 |
Why?
|
Seroepidemiologic Studies | 8 | 2023 | 406 | 0.940 |
Why?
|
Seasons | 5 | 2024 | 1511 | 0.930 |
Why?
|
Communicable Diseases | 3 | 2024 | 892 | 0.910 |
Why?
|
Genomics | 13 | 2023 | 5743 | 0.910 |
Why?
|
Respiratory Syncytial Virus, Human | 2 | 2017 | 143 | 0.910 |
Why?
|
Pharyngitis | 1 | 2024 | 218 | 0.840 |
Why?
|
Cephalosporins | 4 | 2020 | 202 | 0.830 |
Why?
|
Genetic Variation | 5 | 2020 | 6567 | 0.820 |
Why?
|
Streptococcus pyogenes | 1 | 2024 | 291 | 0.800 |
Why?
|
Phylogeny | 14 | 2023 | 2820 | 0.790 |
Why?
|
Influenza A Virus, H3N2 Subtype | 2 | 2018 | 90 | 0.780 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2017 | 340 | 0.770 |
Why?
|
Mumps | 2 | 2020 | 65 | 0.770 |
Why?
|
Drug Resistance, Multiple, Bacterial | 8 | 2020 | 565 | 0.760 |
Why?
|
Drug Prescriptions | 3 | 2019 | 1651 | 0.760 |
Why?
|
Virus Shedding | 1 | 2021 | 113 | 0.750 |
Why?
|
Influenza Vaccines | 2 | 2018 | 762 | 0.750 |
Why?
|
Dermatitis | 1 | 2022 | 200 | 0.750 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2023 | 690 | 0.730 |
Why?
|
Streptococcal Infections | 1 | 2024 | 642 | 0.690 |
Why?
|
Inappropriate Prescribing | 2 | 2021 | 210 | 0.690 |
Why?
|
Tetracycline | 4 | 2024 | 216 | 0.680 |
Why?
|
Disease Transmission, Infectious | 4 | 2021 | 546 | 0.680 |
Why?
|
Longevity | 3 | 2024 | 1085 | 0.660 |
Why?
|
Shiga-Toxigenic Escherichia coli | 2 | 2023 | 27 | 0.660 |
Why?
|
Transportation | 1 | 2020 | 215 | 0.650 |
Why?
|
Mumps Vaccine | 1 | 2018 | 17 | 0.640 |
Why?
|
Ceftriaxone | 4 | 2024 | 174 | 0.620 |
Why?
|
Urethritis | 1 | 2017 | 23 | 0.620 |
Why?
|
Cefixime | 4 | 2023 | 12 | 0.610 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2020 | 371 | 0.600 |
Why?
|
Bacteria | 8 | 2022 | 2145 | 0.600 |
Why?
|
Humans | 113 | 2024 | 752741 | 0.590 |
Why?
|
Bacterial Infections | 4 | 2019 | 1401 | 0.580 |
Why?
|
Genotype | 8 | 2021 | 12970 | 0.580 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2018 | 3605 | 0.570 |
Why?
|
Sequence Analysis, DNA | 7 | 2020 | 4806 | 0.570 |
Why?
|
Fluoroquinolones | 3 | 2023 | 305 | 0.570 |
Why?
|
Cervix Uteri | 1 | 2020 | 591 | 0.550 |
Why?
|
Cholera | 2 | 2013 | 785 | 0.550 |
Why?
|
RNA, Viral | 2 | 2022 | 2908 | 0.550 |
Why?
|
Evolution, Molecular | 6 | 2020 | 1947 | 0.540 |
Why?
|
Vaccination | 7 | 2022 | 3354 | 0.530 |
Why?
|
United States | 25 | 2024 | 70772 | 0.520 |
Why?
|
Public Health | 4 | 2024 | 2634 | 0.520 |
Why?
|
Anti-Infective Agents | 2 | 2023 | 980 | 0.510 |
Why?
|
Outpatients | 6 | 2024 | 1544 | 0.510 |
Why?
|
Listeriosis | 1 | 2016 | 150 | 0.500 |
Why?
|
Models, Theoretical | 5 | 2021 | 3586 | 0.480 |
Why?
|
Coronavirus Infections | 7 | 2020 | 3136 | 0.480 |
Why?
|
Listeria monocytogenes | 1 | 2016 | 252 | 0.470 |
Why?
|
Pneumonia, Viral | 6 | 2020 | 3246 | 0.460 |
Why?
|
Staphylococcus aureus | 3 | 2019 | 1459 | 0.460 |
Why?
|
Bayes Theorem | 7 | 2023 | 2332 | 0.460 |
Why?
|
Escherichia coli | 4 | 2022 | 4248 | 0.460 |
Why?
|
Viral Load | 2 | 2022 | 3325 | 0.450 |
Why?
|
Omeprazole | 2 | 2010 | 117 | 0.440 |
Why?
|
Biological Evolution | 3 | 2021 | 1079 | 0.440 |
Why?
|
Biodiversity | 1 | 2016 | 342 | 0.440 |
Why?
|
Virus Replication | 1 | 2021 | 2538 | 0.440 |
Why?
|
Anti-Ulcer Agents | 2 | 2010 | 119 | 0.440 |
Why?
|
Genome, Viral | 4 | 2020 | 676 | 0.440 |
Why?
|
Health Status Disparities | 4 | 2022 | 1812 | 0.430 |
Why?
|
Post-Exposure Prophylaxis | 2 | 2023 | 102 | 0.430 |
Why?
|
Antibodies, Viral | 7 | 2024 | 3194 | 0.430 |
Why?
|
Nephritis, Interstitial | 2 | 2010 | 155 | 0.430 |
Why?
|
Pandemics | 12 | 2024 | 8607 | 0.420 |
Why?
|
Membrane Transport Proteins | 1 | 2018 | 1041 | 0.420 |
Why?
|
Social Class | 1 | 2021 | 2005 | 0.410 |
Why?
|
Models, Biological | 4 | 2020 | 9569 | 0.410 |
Why?
|
Babesiosis | 1 | 2013 | 92 | 0.400 |
Why?
|
Peptic Ulcer Hemorrhage | 2 | 2010 | 49 | 0.400 |
Why?
|
Viral Proteins | 3 | 2020 | 1899 | 0.400 |
Why?
|
Vibrio cholerae O1 | 1 | 2013 | 242 | 0.390 |
Why?
|
Europe | 5 | 2020 | 3359 | 0.380 |
Why?
|
Residence Characteristics | 1 | 2020 | 2064 | 0.370 |
Why?
|
Anti-Infective Agents, Local | 2 | 2023 | 250 | 0.370 |
Why?
|
Mutation, Missense | 1 | 2020 | 2559 | 0.370 |
Why?
|
Genome-Wide Association Study | 5 | 2023 | 12432 | 0.360 |
Why?
|
Adaptive Immunity | 2 | 2020 | 727 | 0.360 |
Why?
|
Bacterial Vaccines | 3 | 2021 | 406 | 0.350 |
Why?
|
Penicillins | 2 | 2022 | 387 | 0.340 |
Why?
|
RNA, Ribosomal, 23S | 2 | 2020 | 53 | 0.330 |
Why?
|
RNA | 1 | 2019 | 2778 | 0.330 |
Why?
|
Medicare Part C | 1 | 2024 | 298 | 0.330 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1184 | 0.330 |
Why?
|
Immunocompromised Host | 1 | 2014 | 847 | 0.320 |
Why?
|
Helicobacter pylori | 1 | 2011 | 384 | 0.320 |
Why?
|
Helicobacter Infections | 1 | 2011 | 389 | 0.320 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14761 | 0.310 |
Why?
|
Influenza, Human | 2 | 2018 | 1515 | 0.300 |
Why?
|
Repressor Proteins | 2 | 2018 | 3021 | 0.300 |
Why?
|
Lyme Disease | 1 | 2013 | 621 | 0.290 |
Why?
|
beta-Lactam Resistance | 2 | 2017 | 81 | 0.280 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2004 | 1084 | 0.270 |
Why?
|
Genes, Bacterial | 3 | 2020 | 1081 | 0.270 |
Why?
|
Linkage Disequilibrium | 3 | 2020 | 1999 | 0.260 |
Why?
|
Epistasis, Genetic | 2 | 2018 | 364 | 0.260 |
Why?
|
Antibodies, Bacterial | 1 | 2011 | 1475 | 0.260 |
Why?
|
Young Adult | 13 | 2024 | 57267 | 0.260 |
Why?
|
Demography | 2 | 2021 | 1661 | 0.250 |
Why?
|
Mutation | 11 | 2021 | 29981 | 0.250 |
Why?
|
DNA Transposable Elements | 2 | 2019 | 749 | 0.240 |
Why?
|
DNA Footprinting | 1 | 2004 | 98 | 0.240 |
Why?
|
Male | 26 | 2024 | 354311 | 0.240 |
Why?
|
Recombination, Genetic | 2 | 2020 | 1582 | 0.230 |
Why?
|
Vaccines | 2 | 2024 | 842 | 0.230 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2010 | 2287 | 0.230 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2020 | 1124 | 0.220 |
Why?
|
Sexually Transmitted Diseases | 2 | 2019 | 626 | 0.220 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2004 | 792 | 0.220 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7355 | 0.210 |
Why?
|
DNA Gyrase | 1 | 2023 | 82 | 0.210 |
Why?
|
Hexosyltransferases | 1 | 2022 | 59 | 0.210 |
Why?
|
Uncertainty | 2 | 2021 | 744 | 0.210 |
Why?
|
DNA, Bacterial | 3 | 2019 | 1467 | 0.210 |
Why?
|
Chromosome Mapping | 3 | 2014 | 4723 | 0.210 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1984 | 0.200 |
Why?
|
Adaptation, Physiological | 2 | 2018 | 1303 | 0.200 |
Why?
|
Aspirin | 2 | 2010 | 3332 | 0.200 |
Why?
|
Transformation, Bacterial | 2 | 2018 | 78 | 0.200 |
Why?
|
Sequence Alignment | 2 | 2017 | 2250 | 0.200 |
Why?
|
Binding Sites | 2 | 2020 | 6118 | 0.200 |
Why?
|
Adult | 18 | 2024 | 216658 | 0.200 |
Why?
|
Gene Transfer, Horizontal | 2 | 2020 | 145 | 0.190 |
Why?
|
Convalescence | 1 | 2021 | 104 | 0.190 |
Why?
|
Coronaviridae Infections | 1 | 2020 | 10 | 0.190 |
Why?
|
Base Sequence | 5 | 2021 | 12769 | 0.190 |
Why?
|
Haiti | 2 | 2013 | 552 | 0.190 |
Why?
|
Streptococcus pneumoniae | 3 | 2020 | 717 | 0.180 |
Why?
|
Quarantine | 2 | 2020 | 176 | 0.180 |
Why?
|
Mumps virus | 1 | 2020 | 24 | 0.180 |
Why?
|
Prescriptions | 1 | 2023 | 387 | 0.180 |
Why?
|
Immunization, Secondary | 1 | 2022 | 351 | 0.180 |
Why?
|
Cross Reactions | 2 | 2020 | 842 | 0.180 |
Why?
|
England | 2 | 2018 | 528 | 0.180 |
Why?
|
Sexual Behavior | 2 | 2019 | 2072 | 0.170 |
Why?
|
Operon | 1 | 2020 | 365 | 0.170 |
Why?
|
Mass Vaccination | 1 | 2021 | 106 | 0.170 |
Why?
|
Daptomycin | 1 | 2019 | 72 | 0.170 |
Why?
|
Bacterial Typing Techniques | 1 | 2020 | 256 | 0.170 |
Why?
|
Bile Acids and Salts | 1 | 2021 | 378 | 0.170 |
Why?
|
Off-Label Use | 1 | 2021 | 181 | 0.170 |
Why?
|
Fimbriae Proteins | 2 | 2022 | 133 | 0.170 |
Why?
|
Serologic Tests | 1 | 2021 | 378 | 0.170 |
Why?
|
Sample Size | 1 | 2022 | 841 | 0.170 |
Why?
|
Computational Biology | 3 | 2019 | 3531 | 0.170 |
Why?
|
Prevalence | 3 | 2022 | 15404 | 0.160 |
Why?
|
Kinetics | 2 | 2023 | 6482 | 0.160 |
Why?
|
Algorithms | 4 | 2019 | 13984 | 0.160 |
Why?
|
Carbon Dioxide | 1 | 2023 | 1162 | 0.160 |
Why?
|
Antibiotic Prophylaxis | 1 | 2023 | 647 | 0.160 |
Why?
|
Sexual Partners | 2 | 2019 | 743 | 0.160 |
Why?
|
New York City | 1 | 2020 | 719 | 0.160 |
Why?
|
Massachusetts | 2 | 2021 | 8721 | 0.160 |
Why?
|
Nitrite Reductases | 1 | 2017 | 5 | 0.160 |
Why?
|
Adolescent | 9 | 2024 | 86713 | 0.160 |
Why?
|
Carrier State | 4 | 2023 | 520 | 0.150 |
Why?
|
Aged | 10 | 2024 | 165629 | 0.150 |
Why?
|
Child | 7 | 2024 | 78594 | 0.150 |
Why?
|
Propionates | 1 | 2018 | 170 | 0.150 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 5858 | 0.150 |
Why?
|
Ferrets | 1 | 2018 | 195 | 0.150 |
Why?
|
Contact Tracing | 1 | 2020 | 277 | 0.150 |
Why?
|
Health Priorities | 1 | 2021 | 381 | 0.150 |
Why?
|
Selection, Genetic | 2 | 2020 | 920 | 0.150 |
Why?
|
Group Processes | 1 | 2019 | 226 | 0.150 |
Why?
|
R Factors | 1 | 2017 | 44 | 0.150 |
Why?
|
Drosophila | 2 | 2004 | 1505 | 0.150 |
Why?
|
Insurance | 1 | 2018 | 113 | 0.150 |
Why?
|
Communicable Disease Control | 1 | 2024 | 862 | 0.150 |
Why?
|
Risk Assessment | 1 | 2018 | 23554 | 0.150 |
Why?
|
Eggs | 1 | 2018 | 183 | 0.140 |
Why?
|
Infant | 5 | 2024 | 35447 | 0.140 |
Why?
|
Adaptation, Biological | 1 | 2018 | 151 | 0.140 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2017 | 86 | 0.140 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 591 | 0.140 |
Why?
|
Athletes | 2 | 2022 | 1115 | 0.140 |
Why?
|
Middle Aged | 12 | 2024 | 216054 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25454 | 0.140 |
Why?
|
Flavivirus | 1 | 2016 | 20 | 0.140 |
Why?
|
Biosynthetic Pathways | 1 | 2017 | 135 | 0.140 |
Why?
|
Lip | 1 | 2018 | 195 | 0.140 |
Why?
|
Genomic Islands | 1 | 2016 | 50 | 0.140 |
Why?
|
Bacterial Capsules | 1 | 2017 | 252 | 0.140 |
Why?
|
Databases, Genetic | 2 | 2019 | 1780 | 0.140 |
Why?
|
beta-Lactamases | 2 | 2017 | 307 | 0.140 |
Why?
|
Chikungunya virus | 1 | 2016 | 51 | 0.140 |
Why?
|
Fatigue | 3 | 2013 | 1536 | 0.130 |
Why?
|
Carbapenems | 1 | 2017 | 120 | 0.130 |
Why?
|
DNA, Ribosomal | 1 | 2016 | 291 | 0.130 |
Why?
|
Pharynx | 1 | 2018 | 423 | 0.130 |
Why?
|
Molecular Sequence Data | 5 | 2014 | 18050 | 0.130 |
Why?
|
Enterobacteriaceae | 1 | 2017 | 171 | 0.130 |
Why?
|
Pregnant Women | 1 | 2020 | 576 | 0.130 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 158 | 0.130 |
Why?
|
Codon | 1 | 2017 | 612 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.130 |
Why?
|
Enterobacteriaceae Infections | 1 | 2017 | 190 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2020 | 636 | 0.120 |
Why?
|
Host-Pathogen Interactions | 3 | 2019 | 1483 | 0.120 |
Why?
|
Incidence | 2 | 2024 | 21146 | 0.120 |
Why?
|
Computer Simulation | 3 | 2023 | 6190 | 0.120 |
Why?
|
Databases, Protein | 1 | 2016 | 388 | 0.120 |
Why?
|
Antigens, Viral | 1 | 2018 | 1035 | 0.120 |
Why?
|
Caenorhabditis elegans | 1 | 2003 | 1428 | 0.120 |
Why?
|
Stomach Ulcer | 2 | 2010 | 127 | 0.120 |
Why?
|
Probability | 1 | 2019 | 2514 | 0.110 |
Why?
|
Female | 14 | 2024 | 385090 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1788 | 0.110 |
Why?
|
Haplotypes | 1 | 2020 | 2776 | 0.110 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2017 | 881 | 0.110 |
Why?
|
Membrane Proteins | 2 | 2022 | 7941 | 0.110 |
Why?
|
Genetic Markers | 1 | 2019 | 2633 | 0.110 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2013 | 54 | 0.110 |
Why?
|
Gene Frequency | 1 | 2020 | 3591 | 0.110 |
Why?
|
Reference Standards | 1 | 2016 | 1021 | 0.110 |
Why?
|
Nepal | 1 | 2013 | 297 | 0.110 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2013 | 109 | 0.100 |
Why?
|
Zimbabwe | 1 | 2012 | 130 | 0.100 |
Why?
|
Water Purification | 1 | 2012 | 48 | 0.100 |
Why?
|
Age Distribution | 2 | 2023 | 2905 | 0.100 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2014 | 404 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2017 | 1177 | 0.100 |
Why?
|
Urinalysis | 2 | 2010 | 368 | 0.100 |
Why?
|
Child, Preschool | 3 | 2024 | 41390 | 0.100 |
Why?
|
Immunity, Herd | 2 | 2021 | 43 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2019 | 20026 | 0.090 |
Why?
|
Health Services Research | 1 | 2018 | 1838 | 0.090 |
Why?
|
Hospitals | 2 | 2023 | 3986 | 0.090 |
Why?
|
MicroRNAs | 2 | 2003 | 3767 | 0.090 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2018 | 924 | 0.090 |
Why?
|
Models, Genetic | 3 | 2013 | 3489 | 0.090 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 2820 | 0.090 |
Why?
|
Urination Disorders | 1 | 2010 | 241 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2022 | 78758 | 0.080 |
Why?
|
Infant, Newborn | 4 | 2022 | 25903 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1466 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6542 | 0.080 |
Why?
|
Comorbidity | 1 | 2023 | 10450 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9431 | 0.080 |
Why?
|
Phenotype | 3 | 2021 | 16484 | 0.080 |
Why?
|
Boston | 2 | 2017 | 9348 | 0.080 |
Why?
|
Epidemics | 1 | 2013 | 524 | 0.070 |
Why?
|
Research Design | 1 | 2023 | 6118 | 0.070 |
Why?
|
Species Specificity | 2 | 2018 | 2483 | 0.070 |
Why?
|
Mycobacterium tuberculosis | 1 | 2018 | 1889 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18460 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2501 | 0.070 |
Why?
|
Animals | 8 | 2020 | 169600 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 13042 | 0.070 |
Why?
|
Models, Statistical | 1 | 2021 | 5107 | 0.070 |
Why?
|
Diarrhea | 1 | 2013 | 1351 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2013 | 2719 | 0.070 |
Why?
|
Clone Cells | 2 | 2021 | 1692 | 0.070 |
Why?
|
Fever | 1 | 2013 | 1627 | 0.060 |
Why?
|
Sex Factors | 1 | 2019 | 10469 | 0.060 |
Why?
|
Prospective Studies | 3 | 2021 | 53863 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15164 | 0.060 |
Why?
|
Kidney | 2 | 2010 | 7152 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 12054 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2011 | 1684 | 0.060 |
Why?
|
Glucocorticoids | 2 | 2010 | 2129 | 0.060 |
Why?
|
Polyribosomes | 1 | 2003 | 110 | 0.060 |
Why?
|
Consensus Sequence | 1 | 2004 | 378 | 0.060 |
Why?
|
Medical Informatics Computing | 1 | 2003 | 24 | 0.060 |
Why?
|
Erythrocytes | 1 | 2013 | 2463 | 0.060 |
Why?
|
Shiga Toxin | 1 | 2023 | 33 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15657 | 0.060 |
Why?
|
Genes, Regulator | 1 | 2004 | 378 | 0.060 |
Why?
|
Aged, 80 and over | 2 | 2018 | 58361 | 0.060 |
Why?
|
HIV Infections | 2 | 2019 | 16882 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2014 | 3002 | 0.050 |
Why?
|
Mupirocin | 1 | 2022 | 56 | 0.050 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2002 | 130 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13778 | 0.050 |
Why?
|
O Antigens | 1 | 2023 | 193 | 0.050 |
Why?
|
Fimbriae, Bacterial | 1 | 2022 | 138 | 0.050 |
Why?
|
Time Factors | 1 | 2023 | 40195 | 0.050 |
Why?
|
Methicillin Resistance | 1 | 2022 | 198 | 0.050 |
Why?
|
Kenya | 1 | 2024 | 696 | 0.050 |
Why?
|
Rwanda | 1 | 2024 | 711 | 0.050 |
Why?
|
Physicians' Offices | 1 | 2021 | 58 | 0.050 |
Why?
|
Coronaviridae | 1 | 2020 | 13 | 0.050 |
Why?
|
Plasmids | 2 | 2016 | 2316 | 0.050 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 39 | 0.050 |
Why?
|
Masks | 1 | 2023 | 203 | 0.050 |
Why?
|
Coronavirus OC43, Human | 1 | 2020 | 18 | 0.050 |
Why?
|
Voluntary Programs | 1 | 2020 | 43 | 0.050 |
Why?
|
Medicare | 1 | 2018 | 6670 | 0.040 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.040 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 16 | 0.040 |
Why?
|
Victoria | 1 | 2019 | 66 | 0.040 |
Why?
|
Phylogeography | 1 | 2019 | 81 | 0.040 |
Why?
|
Cohort Studies | 2 | 2022 | 40939 | 0.040 |
Why?
|
Topoisomerase Inhibitors | 1 | 2019 | 18 | 0.040 |
Why?
|
Rhinovirus | 1 | 2020 | 191 | 0.040 |
Why?
|
Uganda | 1 | 2024 | 1283 | 0.040 |
Why?
|
Spiro Compounds | 1 | 2019 | 76 | 0.040 |
Why?
|
Drug Utilization Review | 1 | 2020 | 246 | 0.040 |
Why?
|
Acyl Coenzyme A | 1 | 2018 | 55 | 0.040 |
Why?
|
Barbiturates | 1 | 2019 | 111 | 0.040 |
Why?
|
Molecular Structure | 1 | 2003 | 1898 | 0.040 |
Why?
|
New York | 1 | 2021 | 885 | 0.040 |
Why?
|
Time | 1 | 2020 | 548 | 0.040 |
Why?
|
Oxazolidinones | 1 | 2019 | 96 | 0.040 |
Why?
|
Polymorphism, Genetic | 2 | 2021 | 4327 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2022 | 589 | 0.040 |
Why?
|
Penicillin G | 1 | 2017 | 42 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2010 | 3998 | 0.040 |
Why?
|
Privacy | 1 | 2020 | 241 | 0.040 |
Why?
|
Public Health Practice | 1 | 2020 | 217 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 360 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7852 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6954 | 0.040 |
Why?
|
Isoxazoles | 1 | 2019 | 226 | 0.040 |
Why?
|
Africa | 1 | 2019 | 696 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 2018 | 334 | 0.040 |
Why?
|
Cities | 1 | 2019 | 518 | 0.040 |
Why?
|
Smallpox | 1 | 2017 | 45 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 64017 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15657 | 0.040 |
Why?
|
Nasal Cavity | 1 | 2019 | 314 | 0.040 |
Why?
|
Encephalitis Virus, Japanese | 1 | 2016 | 12 | 0.040 |
Why?
|
Yellow fever virus | 1 | 2016 | 22 | 0.040 |
Why?
|
Isoniazid | 1 | 2018 | 281 | 0.040 |
Why?
|
Logistic Models | 1 | 2011 | 13441 | 0.040 |
Why?
|
Glycosylation | 1 | 2019 | 1129 | 0.030 |
Why?
|
Hepatitis A | 1 | 2017 | 132 | 0.030 |
Why?
|
Multilocus Sequence Typing | 1 | 2016 | 99 | 0.030 |
Why?
|
West Nile virus | 1 | 2016 | 79 | 0.030 |
Why?
|
Molecular Typing | 1 | 2016 | 106 | 0.030 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2017 | 137 | 0.030 |
Why?
|
Morpholines | 1 | 2019 | 572 | 0.030 |
Why?
|
Insect Vectors | 1 | 2016 | 135 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 885 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2022 | 797 | 0.030 |
Why?
|
Chromosomes, Bacterial | 1 | 2016 | 283 | 0.030 |
Why?
|
Pneumococcal Vaccines | 1 | 2018 | 393 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 73094 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2020 | 1262 | 0.030 |
Why?
|
Erythromycin | 1 | 2014 | 120 | 0.030 |
Why?
|
Dengue Virus | 1 | 2016 | 203 | 0.030 |
Why?
|
Adhesins, Bacterial | 1 | 2014 | 120 | 0.030 |
Why?
|
Vagina | 1 | 2019 | 830 | 0.030 |
Why?
|
Glycoproteins | 1 | 2022 | 2253 | 0.030 |
Why?
|
Pneumococcal Infections | 1 | 2018 | 502 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 980 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 529 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1360 | 0.030 |
Why?
|
Penicillin-Binding Proteins | 1 | 2014 | 139 | 0.030 |
Why?
|
Minority Groups | 1 | 2021 | 1227 | 0.030 |
Why?
|
Research | 1 | 2022 | 2001 | 0.030 |
Why?
|
Light | 1 | 2019 | 1332 | 0.030 |
Why?
|
Triazoles | 1 | 2019 | 909 | 0.030 |
Why?
|
Polysaccharides | 1 | 2019 | 1050 | 0.030 |
Why?
|
World Health Organization | 1 | 2019 | 1330 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2004 | 3626 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2215 | 0.030 |
Why?
|
China | 1 | 2018 | 2306 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 1255 | 0.030 |
Why?
|
Canada | 1 | 2017 | 2081 | 0.030 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 425 | 0.030 |
Why?
|
Cost of Illness | 1 | 2021 | 1873 | 0.020 |
Why?
|
Point Mutation | 1 | 2016 | 1619 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2031 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2023 | 5410 | 0.020 |
Why?
|
Decision Making | 1 | 2024 | 3909 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 2018 | 1358 | 0.020 |
Why?
|
Software | 1 | 2004 | 4460 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3012 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2049 | 0.020 |
Why?
|
Histamine H2 Antagonists | 1 | 2010 | 167 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2010 | 389 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3356 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2642 | 0.020 |
Why?
|
Genome | 1 | 2016 | 1806 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4403 | 0.020 |
Why?
|
Oxygen | 1 | 2019 | 4208 | 0.020 |
Why?
|
Cross Infection | 1 | 2017 | 1428 | 0.020 |
Why?
|
Health Policy | 1 | 2020 | 2687 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2210 | 0.020 |
Why?
|
HIV | 1 | 2014 | 1610 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3757 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4077 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7970 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2215 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 1893 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7805 | 0.020 |
Why?
|
Neurons | 1 | 2003 | 9439 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5380 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5710 | 0.010 |
Why?
|
Cell Fractionation | 1 | 2003 | 252 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10422 | 0.010 |
Why?
|
3' Flanking Region | 1 | 2002 | 15 | 0.010 |
Why?
|
HIV-1 | 1 | 2020 | 6981 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2002 | 105 | 0.010 |
Why?
|
Base Composition | 1 | 2002 | 293 | 0.010 |
Why?
|
Genes, Insect | 1 | 2002 | 266 | 0.010 |
Why?
|
Acute Disease | 1 | 2010 | 7221 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39223 | 0.010 |
Why?
|
Mesoderm | 1 | 2002 | 685 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2002 | 1191 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6771 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 6037 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 2123 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2002 | 1343 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2003 | 1428 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2002 | 1730 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1717 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2002 | 2423 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2003 | 19270 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 2003 | 5725 | 0.000 |
Why?
|
Rats | 1 | 2003 | 24248 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9664 | 0.000 |
Why?
|
Transcription Factors | 1 | 2002 | 12165 | 0.000 |
Why?
|
Mice | 1 | 2003 | 81766 | 0.000 |
Why?
|